NIIT Learning Systems Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 12, 2025, 3:43 am

Competitors of NIIT Learning Systems Ltd

All Competitor Stocks of NIIT Learning Systems Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:15 am

Below is a detailed analysis of the quarterly data for NIIT Learning Systems Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 451.00 Cr.. The value appears strong and on an upward trend. It has increased from 430.00 Cr. (Mar 2025) to 451.00 Cr., marking an increase of 21.00 Cr..
• For Expenses, as of Jun 2025, the value is 361.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 350.00 Cr. (Mar 2025) to 361.00 Cr., marking an increase of 11.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 10.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 19.00% (Mar 2025) to 20.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 69.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from 30.00% (Mar 2025) to 32.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 49.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.61. The value appears strong and on an upward trend. It has increased from 3.58 (Mar 2025) to 3.61, marking an increase of 0.03.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:45 am

Growth

Last Updated: September 5, 2025, 11:40 am

Balance Sheet

Last Updated: November 9, 2025, 2:36 pm

Below is a detailed analysis of the balance sheet data for NIIT Learning Systems Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,308.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,183.00 Cr. (Mar 2025) to 1,308.00 Cr., marking an increase of 125.00 Cr..
• For Borrowings, as of Sep 2025, the value is 260.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 103.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 157.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 974.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 874.00 Cr. (Mar 2025) to 974.00 Cr., marking an increase of 100.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,569.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,186.00 Cr. (Mar 2025) to 2,569.00 Cr., marking an increase of 383.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 848.00 Cr.. The value appears strong and on an upward trend. It has increased from 629.00 Cr. (Mar 2025) to 848.00 Cr., marking an increase of 219.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 10.00 Cr..
• For Investments, as of Sep 2025, the value is 485.00 Cr.. The value appears strong and on an upward trend. It has increased from 425.00 Cr. (Mar 2025) to 485.00 Cr., marking an increase of 60.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,236.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,123.00 Cr. (Mar 2025) to 1,236.00 Cr., marking an increase of 113.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,569.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,186.00 Cr. (Mar 2025) to 2,569.00 Cr., marking an increase of 383.00 Cr..

Notably, the Reserves (1,308.00 Cr.) exceed the Borrowings (260.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for NIIT Learning Systems Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.75. This value is within the healthy range. It has increased from 15.82 (Mar 24) to 16.75, marking an increase of 0.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 16.15. This value is within the healthy range. It has increased from 15.22 (Mar 24) to 16.15, marking an increase of 0.93.
• For Cash EPS (Rs.), as of Mar 25, the value is 21.26. This value is within the healthy range. It has increased from 20.12 (Mar 24) to 21.26, marking an increase of 1.14.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 88.88. It has increased from 72.19 (Mar 24) to 88.88, marking an increase of 16.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 88.88. It has increased from 72.19 (Mar 24) to 88.88, marking an increase of 16.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 121.45. It has increased from 114.74 (Mar 24) to 121.45, marking an increase of 6.71.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 29.40. This value is within the healthy range. It has increased from 29.11 (Mar 24) to 29.40, marking an increase of 0.29.
• For PBIT / Share (Rs.), as of Mar 25, the value is 24.85. This value is within the healthy range. It has increased from 24.74 (Mar 24) to 24.85, marking an increase of 0.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 22.51. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 22.51, marking an increase of 0.57.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 16.71. This value is within the healthy range. It has increased from 15.75 (Mar 24) to 16.71, marking an increase of 0.96.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.71. This value is within the healthy range. It has increased from 15.75 (Mar 24) to 16.71, marking an increase of 0.96.
• For PBDIT Margin (%), as of Mar 25, the value is 24.20. This value is within the healthy range. It has decreased from 25.37 (Mar 24) to 24.20, marking a decrease of 1.17.
• For PBIT Margin (%), as of Mar 25, the value is 20.46. This value exceeds the healthy maximum of 20. It has decreased from 21.56 (Mar 24) to 20.46, marking a decrease of 1.10.
• For PBT Margin (%), as of Mar 25, the value is 18.53. This value is within the healthy range. It has decreased from 19.12 (Mar 24) to 18.53, marking a decrease of 0.59.
• For Net Profit Margin (%), as of Mar 25, the value is 13.76. This value exceeds the healthy maximum of 10. It has increased from 13.72 (Mar 24) to 13.76, marking an increase of 0.04.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.76. This value is within the healthy range. It has increased from 13.72 (Mar 24) to 13.76, marking an increase of 0.04.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.80. This value is within the healthy range. It has decreased from 21.81 (Mar 24) to 18.80, marking a decrease of 3.01.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.16. This value is within the healthy range. It has decreased from 27.14 (Mar 24) to 24.16, marking a decrease of 2.98.
• For Return On Assets (%), as of Mar 25, the value is 10.39. This value is within the healthy range. It has decreased from 10.48 (Mar 24) to 10.39, marking a decrease of 0.09.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.09 (Mar 24) to 0.05, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 0.83 (Mar 24) to 0.78, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 1.88, marking an increase of 0.22.
• For Quick Ratio (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 1.88, marking an increase of 0.22.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 20,537.44. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 20,537.44, marking an increase of 20,537.44.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 16.41. This value is below the healthy minimum of 20. It has increased from 15.79 (Mar 24) to 16.41, marking an increase of 0.62.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.90. This value is below the healthy minimum of 20. It has increased from 12.36 (Mar 24) to 12.90, marking an increase of 0.54.
• For Earning Retention Ratio (%), as of Mar 25, the value is 83.59. This value exceeds the healthy maximum of 70. It has decreased from 84.21 (Mar 24) to 83.59, marking a decrease of 0.62.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.10. This value exceeds the healthy maximum of 70. It has decreased from 87.64 (Mar 24) to 87.10, marking a decrease of 0.54.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 19.21. This value is within the healthy range. It has increased from 12.05 (Mar 24) to 19.21, marking an increase of 7.16.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.46. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 12.46, marking an increase of 4.78.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,295.01. It has decreased from 6,649.85 (Mar 24) to 5,295.01, marking a decrease of 1,354.84.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 3. It has decreased from 4.28 (Mar 24) to 3.20, marking a decrease of 1.08.
• For EV / EBITDA (X), as of Mar 25, the value is 13.23. This value is within the healthy range. It has decreased from 16.87 (Mar 24) to 13.23, marking a decrease of 3.64.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 4.40 (Mar 24) to 3.37, marking a decrease of 1.03.
• For Retention Ratios (%), as of Mar 25, the value is 83.58. This value exceeds the healthy maximum of 70. It has decreased from 84.20 (Mar 24) to 83.58, marking a decrease of 0.62.
• For Price / BV (X), as of Mar 25, the value is 4.60. This value exceeds the healthy maximum of 3. It has decreased from 7.00 (Mar 24) to 4.60, marking a decrease of 2.40.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 4.40 (Mar 24) to 3.37, marking a decrease of 1.03.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness